• Inhibits HR activity and anticancer activity in cells expressing activation-induced cytidine deaminase (AID), a protein that promotes formation of DSBs.• Shows synergy with cisplatin, PARP and ATR inhibitors in various cancer cells by inducing synthetic lethality. IC50 = 20 nM-5 μM. Here, PARP1 is linked to cancer.